Skip to content
Home » Tomorrow Medical Co., Ltd. Tomorrow Medical and three companies of the Sugi Pharmacy Group have entered into a business alliance. The second edition of the specialist-supervised supplement series “d’fine(R)” is now on sale.

Tomorrow Medical Co., Ltd. Tomorrow Medical and three companies of the Sugi Pharmacy Group have entered into a business alliance. The second edition of the specialist-supervised supplement series “d’fine(R)” is now on sale.

[Tomorrow Medical Co., Ltd.] Tomorrow
Medical and three companies of the Sugi Pharmacy Group have entered into a business alliance. The second edition of the
specialist-supervised supplement series “d’fine(R)” is now on sale.
*View in browser* *Tomorrow Medical Co., Ltd.*
Press release: June 3, 2024
**
Tomorrow Medical and three companies of the Sugi Pharmacy Group have entered into a business alliance. The second edition of the
specialist-supervised supplement series “d’fine(R)” is now on sale. Tomorrow Medical Co., Ltd. (Headquarters: Chiyoda-ku, Tokyo, Representative Director and CEO: Tatsuo Hasebe, hereinafter referred to as Tomorrow)
Medical) and Sugi Pharmacy Group’s Sugi Pharmacy Co., Ltd.
(Headquarters: Obu City, Aichi Prefecture, Representative Director and President Sugiura)
Katsunori), Sugi Medical Co., Ltd. (Head office: Chiyoda-ku, Tokyo, Representative Director and President: Shinya Sugiura), S Trading Co., Ltd. (Head office: Obu City, Aichi Prefecture, Representative Director and CEO)
: Yamamoto
Tsuyoshi) has concluded a business partnership agreement. Through activities based on this business partnership agreement, we will begin selling the second edition of the specialist-supervised supplement series “d’fine(R)” at Sugi pharmacies nationwide from May 31, 2024.

business partnership
Tomorrow
Medical and the three companies of the Sugi Pharmacy Group have entered into a business alliance agreement to cooperate in the healthcare field, jointly develop products in the preventive medicine field, and expand their products domestically and internationally. On January 15, 2024, we began selling four products as the first in the d’fine series: Minerals & Vitamins, Collagen Peptides, NMN5000, and Euglena Gracilis. Due to popular demand, we are now launching the second batch of three products.

2nd product lineup
DHA&EPA
Lactic acid bacteria & butyric acid bacteria
Kwansou
* DHA & EPA * * Lactic acid bacteria & Butyric acid bacteria * * Quansou * *Suggested retail price* 2,480 yen (excluding tax)
2,678 yen (tax included) 2,480 yen (tax excluded)
2,678 yen (tax included) 1,980 yen (tax excluded)
2,138 yen (tax included)
*Supervising doctor* Dr. Mitsuruji Sugioka
Professor Yoshimasa Goto
Mr. Hiroshi Sasaki Mr. Hiroshi Sasaki
Mr. Ken Hanyu Mr. Masayuki Takashima
Professor Takao Oikawa
Professor Yoshimasa Goto
Please check the homepage for details.
See details

What is d’fine(R)?
d’fine(R) is a supplement series supervised by a specialist that includes three fines.
1) Commitment to health: Supporting a healthy daily life
2) Commitment to raw materials: Blending high-quality raw materials in appropriate amounts
3) Commitment to quality: Manufactured at a GMP certified factory of Nissei Kosan Co., Ltd.
Because we are specialists in the medical field, we emphasize the importance of prevention, and from the perspective of supporting a healthy daily life, we received the cooperation of each doctor in the supervision. This supplement is created with the desire to support healthy people’s daily lives by supplementing nutrients that tend to be lacking in their lifestyles.
[Reference]
The d’fine(R) logo is a collection of motifs of the initial letter “D” of DOCTOR. It expresses the gathering of diverse wisdom of experts.

Overview of each social company
*Tomorrow Medical Co., Ltd.*
Representative: Representative Director Tatsuo Hasebe
Head office location: 3rd floor, Nippon Life Marunouchi Garden Tower, 1-1-3 Marunouchi, Chiyoda-ku, Tokyo
Business details: A startup that brings together the strengths of specialists in each medical department and develops new businesses with the theme of “creating new value that will lead to tomorrow’s medical care.” In addition to our own business development, we are also supporting new business development in the medical and healthcare field for various companies, and are currently engaged in multiple collaborative business development projects.
HP: https://tomorrowmedical.co.jp/

*Sugi Pharmacy Co., Ltd.*
Representative: Katsunori Sugiura, President and Representative Director Head office location: 62-1 Arae, Yokone-cho, Obu-shi, Aichi Prefecture Business details: Operation of a community-based drug store that also supports home medical care.
HP: https://www.drug-sugi.co.jp/

*Sugi Medical Co., Ltd.*
Representative: Shinya Sugiura, President and Representative Director Head office location: 2nd floor, Horiuchi Building, 2-6-1 Kajicho, Chiyoda-ku, Tokyo
Business content: Business management and operation of all Sugi Medical Group companies
HP: https://www.sugi-hd.co.jp/sugi-medical/

*S Trading Co., Ltd.*
Representative: Takeshi Yamamoto, Representative Director and President Head office location: 1-8-4 Mikawa Anjo-cho, Anjo City, Aichi Prefecture Business content: Trading business, domestic wholesale business, retail support business, cross-border EC business
HP: https://www.strading.co.jp/

* Nissei Kosan Co., Ltd. (Nippon Medoc Co., Ltd.) *
Representative: Representative Director Tadashi Fujita
Head office location: 2-7-4 Hishie, Higashiosaka City, Osaka Prefecture Business content: Development and manufacturing of nutritional supplements and functional foods
HP: https://www.nisseikohsan.com/
*About this release details*
https://prtimes.jp/main/html/rd/p/000000006.000120027.html

*Download press release materials*
https://prtimes.jp/im/action.php?run=html&page=releaseimage&company_id=120027&release_id=6